Barocci S, Nocera A
Department of Immunology, San Martino Hospital, Genoa, Italy.
Transpl Int. 1993 Jan;6(1):29-33. doi: 10.1007/BF00336636.
In the present study we compared the capabilities of sepharose-bound protein A versus protein G columns to remove in vitro lymphocytotoxic anti-HLA antibodies from sera of four highly sensitized renal transplant recipients (PRA > or = 70%). In none of the patients were protein A sepharose columns capable of completely removing anti-HLA antibodies, as demonstrated by the presence of residual alloreactive lymphocytotoxic activity in IgG3 antibodies containing fractions eluted at pH 7. In contrast, no residual anti-HLA lymphocytotoxic antibody activity was found in fractions eluted at pH 7 from protein G columns. These data demonstrate that: (1) IgG 3 antibodies can be partly responsible for lymphocytotoxic anti-HLA reactivity in some sensitized renal transplant recipients and (2) at least in this patient category, in vitro immunoadsorption with protein G is more efficient than protein A sepharose columns in completely removing anti-HLA IgG antibodies from sera.
在本研究中,我们比较了琼脂糖结合蛋白A柱与蛋白G柱从四名高度致敏的肾移植受者(群体反应性抗体[PRA]≥70%)血清中去除体外淋巴细胞毒性抗HLA抗体的能力。在任何一名患者中,蛋白A琼脂糖柱均无法完全去除抗HLA抗体,这通过在pH 7洗脱的含IgG3抗体的组分中存在残余的同种异体反应性淋巴细胞毒性活性得以证明。相比之下,从蛋白G柱在pH 7洗脱的组分中未发现残余的抗HLA淋巴细胞毒性抗体活性。这些数据表明:(1)IgG3抗体在一些致敏的肾移植受者中可能部分导致淋巴细胞毒性抗HLA反应性,并且(2)至少在这类患者中,用蛋白G进行体外免疫吸附在从血清中完全去除抗HLA IgG抗体方面比蛋白A琼脂糖柱更有效。